Bruker (BRKR) Debt to Equity (2010 - 2026)

Bruker has reported Debt to Equity for 17 years, with the latest figure at $0.68 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity fell 41.26% year-over-year to $0.68; the trailing twelve-month figure through Mar 2026 stood at $0.68 (down 41.26% YoY), and the FY2025 full-year result was $0.76, down 34.3% from the prior year.
• Debt to Equity for Q1 2026 stood at $0.68, down from $0.76 in the prior quarter.
• The five-year high for Debt to Equity was $1.34 in Q2 2025, with the low at $0.68 in Q1 2026.
• Historically, Debt to Equity has averaged $1.05 across 5 years, with a median of $1.07 in 2022.
• Annual changes were most pronounced in 2022 — Debt to Equity surged 60.36% — and 2026, when it tumbled 41.26%.
• Bruker's Debt to Equity stood at $1.07 in 2022, then declined by 14.41% to $0.92 in 2023, then gained by 25.16% to $1.15 in 2024, then sank by 34.3% to $0.76 in 2025, then slipped by 10.35% to $0.68 in 2026.
• The last three Debt to Equity figures came in at $0.68 (Q1 2026), $0.76 (Q4 2025), and $0.83 (Q3 2025), per Business Quant data.